EARNEST Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-99
| Closed | -$18K | – | 1199 |
|
2021
Q2 | $18K | Hold |
99
| – | – | ﹤0.01% | 517 |
|
2021
Q1 | $15K | Hold |
99
| – | – | ﹤0.01% | 540 |
|
2020
Q4 | $15K | Hold |
99
| – | – | ﹤0.01% | 525 |
|
2020
Q3 | $11K | Hold |
99
| – | – | ﹤0.01% | 549 |
|
2020
Q2 | $11K | Hold |
99
| – | – | ﹤0.01% | 550 |
|
2020
Q1 | $9K | Hold |
99
| – | – | ﹤0.01% | 551 |
|
2019
Q4 | $11K | Hold |
99
| – | – | ﹤0.01% | 584 |
|
2019
Q3 | $10K | Hold |
99
| – | – | ﹤0.01% | 595 |
|
2019
Q2 | $13K | Hold |
99
| – | – | ﹤0.01% | 532 |
|
2019
Q1 | $13K | Hold |
99
| – | – | ﹤0.01% | 521 |
|
2018
Q4 | $10K | Hold |
99
| – | – | ﹤0.01% | 554 |
|
2018
Q3 | $14K | Hold |
99
| – | – | ﹤0.01% | 507 |
|
2018
Q2 | $12K | Hold |
99
| – | – | ﹤0.01% | 536 |
|
2018
Q1 | $11K | Hold |
99
| – | – | ﹤0.01% | 549 |
|
2017
Q4 | $12K | Buy |
+99
| New | +$12K | ﹤0.01% | 521 |
|
2017
Q1 | – | Sell |
-99
| Closed | -$12K | – | 1019 |
|
2016
Q4 | $12K | Buy |
+99
| New | +$12K | ﹤0.01% | 492 |
|